Big News: FDA is moving from MasterControl to ComplianceQuest.See Why
Talk to a SpecialistLoading…
Talk to a SpecialistTalk to a SpecialistBased on limited metadata, Safari Stem Cell, LLC received an FDA Warning Letter on April 5, 2024, regarding veterinary products or services. Without access to the full warning letter text or specific subject line details, the exact nature of the violations cannot be determined from the available information. The letter was issued under FDA's veterinary product regulatory authority, though the specific issuing office and violation count are not documented in the metadata provided. A review of the complete letter would be necessary to identify the specific compliance concerns and required corrective actions.